GALLBLADDER CARCINOMA
Clinical trials for GALLBLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GALLBLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for GALLBLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill joins fight against tough bile duct cancers
Disease control OngoingThis study is testing if adding a new pill called selumetinib to standard chemotherapy helps people with advanced bile duct or gallbladder cancer more than chemotherapy alone. It will compare two different schedules of the drug combination. The main goal is to see if the new comb…
Matched conditions: GALLBLADDER CARCINOMA
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis large national trial is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control over 50 different types of rare cancers that have few or no standard treatment options. It enrolled over 800 adults whose rare cancers had progressed …
Matched conditions: GALLBLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New combo therapy targets Tough-to-Treat gut cancers
Disease control OngoingThis study is testing whether adding a drug called tucatinib to standard cancer treatments is safe and effective for people with HER2-positive cancers of the digestive system, like stomach, colon, and gallbladder cancers. It involves about 40 participants who have advanced cancer…
Matched conditions: GALLBLADDER CARCINOMA
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC